Clinical Trial: Phase III ALTU-135 CP Safety Trial
Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: An Open-Label Clinical Study Evaluating the Long Term Safety of ALTU-135 in the Treatment of Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis or
Brief Summary: This is an open-label, single-arm clinical study investigating the long-term safety of ALTU-135 treatment in Chronic Pancreatitis (CP) patients with exocrine Pancreatic Insufficiency (PI).
Detailed Summary:
Sponsor: Anthera Pharmaceuticals
Current Primary Outcome: Number of participants with an adverse event [ Time Frame: Baseline up to 12 months ]
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Anthera Pharmaceuticals
Dates:
Date Received: July 10, 2007
Date Started: December 2007
Date Completion:
Last Updated: October 15, 2014
Last Verified: October 2014